Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson's disease.
10.19540/j.cnki.cjcmm.20230103.705
- Author:
Yan XU
1
;
Xue MENG
1
;
Wen-Xue ZHAO
1
;
Dong-Guang LIU
1
;
Jian-Guo ZHU
1
;
Ru YAO
1
;
Jing-Chun YAO
1
;
Gui-Min ZHANG
1
Author Information
1. New Drug Pharmacology Center of Lunan Pharmaceutical Group Linyi 276006,China State Key Laboratory of Generic Technology of Traditional Chinese Medicine Linyi 276006,China.
- Publication Type:Journal Article
- Keywords:
Parkinson′s disease;
cerebral neuron;
drosophila;
ginsenoside Re;
mitochondrial homeostasis;
oxidative stress
- MeSH:
Animals;
Reactive Oxygen Species/metabolism*;
Antioxidants/pharmacology*;
Oxidative Stress;
NF-E2-Related Factor 2/metabolism*;
Caspase 3/metabolism*;
Parkinson Disease/genetics*;
bcl-2-Associated X Protein/metabolism*;
Neuroprotective Agents/pharmacology*;
Kelch-Like ECH-Associated Protein 1/metabolism*;
Drosophila/metabolism*;
Proto-Oncogene Proteins c-bcl-2/metabolism*;
Apoptosis;
Superoxide Dismutase/metabolism*;
Adenosine Triphosphate/pharmacology*
- From:
China Journal of Chinese Materia Medica
2023;48(7):1927-1935
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to explore the neuroprotective mechanism of ginsenoside Re(GS-Re) on drosophila model of Parkinson's disease(PD) induced by rotenone(Rot). To be specific, Rot was used to induce PD in drosophilas. Then the drosophilas were grouped and respectively treated(GS-Re: 0.1, 0.4, 1.6 mmol·L~(-1); L-dopa: 80 μmol·L~(-1)). Life span and crawling ability of drosophilas were determined. The brain antioxidant activity [content of catalase(CAT), malondialdehyde(MDA), reactive oxygen species(ROS), superoxide dismutase(SOD)], dopamine(DA) content, and mitochondrial function [content of adenosine triphosphate(ATP), NADH:ubiquinone oxidoreductase subunit B8(NDUFB8) Ⅰ activity, succinate dehydrogenase complex, subunit B(SDHB) Ⅱ activity] were detected by enzyme-linked immunosorbent assay(ELISA). The number of DA neurons in the brains of drosophilas was measured with the immunofluorescence method. The levels of NDUFB8 Ⅰ, SDHB Ⅱ, cytochrome C(Cyt C), nuclear factor-E2-related factor 2(Nrf2), heme oxygenase-1(HO-1), B-cell lymphoma/leukemia 2(Bcl-2)/Bcl-2-assaciated X protein(Bax), and cleaved caspase-3/caspase-3 in the brain were detected by Western blot. The results showed that model group [475 μmol·L~(-1) Rot(IC_(50))] demonstrated significantly low survival rate, obvious dyskinesia, small number of neurons and low DA content in the brain, high ROS level and MDA content, low content of SOD and CAT, significantly low ATP content, NDUFB8 Ⅰ activity, and SDHB Ⅱ activity, significantly low expression of NDUFB8 Ⅰ, SDHB Ⅱ, and Bcl-2/Bax, large amount of Cyt C released from mitochondria to cytoplasm, low nuclear transfer of Nrf2, and significantly high expression of cleaved caspase-3/caspase-3 compared with the control group. GS-Re(0.1, 0.4, and 1.6 mmol·L~(-1)) significantly improved the survival rate of PD drosophilas, alleviated the dyskinesia, increased DA content, reduced the loss of DA neurons, ROS level, and MDA content in brain, improved content of SOD and CAT and antioxidant activity in brain, maintained mitochondrial homeostasis(significantly increased ATP content and activity of NDUFB8 Ⅰ and SDHB Ⅱ, significantly up-regulated expression of NDUFB8 Ⅰ, SDHB Ⅱ, and Bcl-2/Bax), significantly reduced the expression of Cyt C, increased the nuclear transfer of Nrf2, and down-regulated the expression of cleaved caspase-3/caspase-3. In conclusion, GS-Re can significantly relieve the Rot-induced cerebral neurotoxicity in drosophilas. The mechanism may be that GS-Re activates Keap1-Nrf2-ARE signaling pathway by maintaining mitochondrial homeostasis, improves antioxidant capacity of brain neurons, then inhibits mitochondria-mediated caspase-3 signaling pathway, and the apoptosis of neuronal cells, thereby exerting the neuroprotective effect.
